Biotech

XBiotech Inc (NASDAQ:XBIT) shares were up 19.02% to $24.90 on Friday as the company saw favorable phase III clinical trial results for Xilonix. The company has a market cap of $958 million at 32.35 million shares outstanding. Shares have been trading in a 52-week range of $21.08 to $25.00...

Xencor Inc (NASDAQ:XNCR) shares rose 32.06% to $16.56 on Tuesday after the company officially signed its collaboration agreement with Novartis AG (ADR) (NYSE:NVS), which has agreed to pay $150 million to have access to Xencor's top two product candidates. Xencor is a clinical-stage biopharmaceutical company that is focused on discovering and developing engineered...

Cerus Corporation (NASDAQ:CERS) shares closed at $6.14 on Tuesday after the company gained financial support of up to $180 million from the U.S. Biomedical Advanced Research and Development Authority. With this agreement, the company can  continue to develop its Intercept Blood System, using the funds to support continued clinical development of...

EXACT Sciences Corporation (NASDAQ:EXAS) shares were up an additional 5.96% to $9.95 in after-hours trading on Tuesday, reflecting significant upward momentum for the stock. The rally has taken place on higher than usual volume as 17 million shares have traded hands versus the daily average of 2 million. EXACT Sciences...

KemPharm Inc (NASDAQ:KMPH) shares were down 5.41% to $6.29 on Monday and have fallen by an additional 30.05% to $4.40 in after-hours trading. The company received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its new drug application (NDA) for Apadaz. Apadaz is an immediate...